Skip to content

Effect of marcaine infiltration to uterin tubes and mesosalpinx on postoperative pain in postpartum tubal ligation

Effect of marcaine infiltration to uterin tubes and mesosalpinx on postoperative pain in postpartum tubal ligation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201110164868N4
Enrollment
30
Registered
2011-12-05
Start date
2009-04-04
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the genitourinary system. Noninflammatory disorders of ovary, fallopian tube and broad ligament

Interventions

Intervention 1: Intervention:15paitentes selected for postpartum tubal ligation had infiltration of five cc marcaine 0.5% in the medial and lateral portion of uterine tube and mesosalpinx. Intervent
Treatment - Drugs
Placebo
Intervention:15paitentes selected for postpartum tubal ligation had infiltration of five cc marcaine 0.5% in the medial and lateral portion of uterine tube and mesosalpinx
Control : 15paitentes selected for postpartum tubal ligation had infiltration of five cc normalsalin in the medial and lateral portion of uterine tube and mesosalpinx

Sponsors

Vice -chancellor for research, Qazvin university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria : Patient acceptance ;Healthy cases in ASA calss I and II;Age range 25 – 40 ;Weight range 50-80 exclusion criteria : All patients not included in inclusion criteria ;Appearance of any complications during operation

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Postoperation pain. Timepoint: 3hours and 24 hours after surjery. Method of measurement: Visual analog scale.

Secondary

MeasureTime frame
Analgesic need. Timepoint: In 24 hoursof surjery. Method of measurement: Dose of drug.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Khadijeh Elmizadeh

Qazvin , university of medical sciences

khelmizadeh@qums.ac.ir+98 28 1333 6001

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026